Dr. Jia Ruan

Weill Cornell Medicine Awarded $9 Million Prestigious Grant for Mantle Cell Lymphoma Research

November 26, 2018

Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time.

Read full article

Dr. Augustine M.K. Choi, Dr. Christopher Mason, Dr. Giorgio Inghirami, Dr. Jia Ruan, Dr. Jihye Paik, Dr. John Leonard, Dr. Lewis C. Cantley, Dr. Lorenzo Galluzzi, Dr. Maurizio Di Liberto, Dr. Olivier Elemento, Dr. Peter Martin, Dr. Selina Chen-Kiang, Dr. Xiangao Huang, Dr. Zhengming Chen, Graduate School of Medical Sciences, Institutional, News from WCM

News from WCM

Non-Chemotherapy Drugs for Mantle Cell Lymphoma Worthy of Continued Study

November 6, 2017

Newer, non-chemotherapy drugs benefit many patients with mantle cell lymphoma, an incurable form of blood cancer, and deserve deeper study in clinical trials, according to an editorial published Sept. 12 in Blood by scientists at Weill Cornell Medicine and NewYork-Presbyterian.

Read full article

Dr. Jia Ruan, Dr. John Leonard, Dr. Peter Martin, Patient Care, Research, News from WCM

News from WCM

Improving the Odds

January 6, 2016

For decades, Weill Cornell has been a leader in the research revolution that's making lymphoma a survivable disease.

Read full article

Center for Lymphoma and Myeloma, Cornell University, Dr. Ari Melnick, Dr. Jia Ruan, Dr. John Leonard, Dr. Leandro Cerchietti, Dr. Lisa Roth, Dr. Morton Coleman, Dr. Peter Martin, Dr. Richard Furman, News from WCM